Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Auteurs » - entrée « C. Bergeron »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
C. Benna < C. Bergeron < C. Berk  Facettes :

List of bibliographic references indexed by C. Bergeron

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
003621 (1999) A S Pakiam [Canada] ; C. Bergeron ; A E LangDiffuse Lewy body disease presenting as multiple system atrophy.
003C98 (1996) C. Bergeron ; C. Petrunka ; L. Weyer ; M. S. PollanenAltered neurofilament expression does not contribute to Lewy body formation.
003D94 (1996) C. Bergeron [Canada] ; M. S. Pollanen ; L. Weyer ; S. E. Black [Canada] ; A. E. LangUnusual clinical presentations of cortical‐basal ganglionic degeneration
003E94 (1996) SANJAY KALRA [Canada] ; C. Bergeron [Canada] ; A. E. Lang [Canada]Lewy body disease and dementia : A review
003F03 (1996) C. Bergeron [Canada] ; C. Petrunka ; L. WeyerCopper/zinc superoxide dismutase expression in the human central nervous system : correlation with selective neuronal vulnerability
004115 (1994) A E Lang [Canada] ; C. Bergeron ; M S Pollanen ; P. AshbyParietal Pick's disease mimicking cortical-basal ganglionic degeneration.
004267 (1994) M. S. Pollanen [Canada] ; C. Bergeron [Canada] ; L. Weyer [Canada]Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments
004438 (1993) M. S. Pollanen [Canada] ; D. W. Dickson ; C. BergeronPathology and biology of the Lewy body
004651 (1992) M. S. Pollanen [Canada] ; C. Bergeron ; L. WeyerDetergent-insoluble cortical lewy body fibrils share epitopes with neurofilament and τ
004859 (1990) T L Perry [Canada] ; C. Bergeron ; J C Steele ; D R Mclachlan ; S. HansenBrain amino acid contents are dissimilar in sporadic and Guamanian amyotrophic lateral sclerosis.
004A15 (1989) C. Bergeron [Canada] ; M. PollanenLewy bodies in Alzheimer disease--one or two diseases?
004C77 (1987) P. Seeman [Canada] ; N H Bzowej ; H C Guan ; C. Bergeron ; G P Reynolds ; E D Bird ; P. Riederer ; K. Jellinger ; W W TourtellotteHuman brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
004D81 (1987) T. L. Perry ; VOON WEE YONG ; S. Hansen ; K. Jones ; C. Bergeron ; J. G. Foulks ; J. M. Wrightα-Tocopherol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "C. Bergeron" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "C. Bergeron" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    C. Bergeron
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022